Interleukin 26: Difference between revisions
CSV import |
CSV import |
||
| Line 21: | Line 21: | ||
{{Immunology-stub}} | {{Immunology-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 15:12, 17 March 2025
Interleukin 26 (IL-26) is a cytokine that is part of the interleukin family, specifically the IL-10 subfamily. It is encoded by the IL26 gene in humans and is involved in inflammatory and immune responses.
Function[edit]
IL-26 is produced by T cells, particularly Th17 cells, in response to infection or inflammation. It acts on various cell types, including epithelial cells, endothelial cells, and monocytes, to induce the production of pro-inflammatory cytokines and chemokines. This leads to the recruitment and activation of neutrophils, enhancing the immune response.
Role in Disease[edit]
IL-26 has been implicated in several diseases, including rheumatoid arthritis, psoriasis, and inflammatory bowel disease. It is thought to contribute to the pathogenesis of these diseases by promoting inflammation and tissue damage.
Therapeutic Potential[edit]
Due to its role in inflammation and immune responses, IL-26 is being investigated as a potential therapeutic target for inflammatory and autoimmune diseases. Inhibiting IL-26 activity could potentially reduce inflammation and tissue damage in these conditions.
See Also[edit]

This article is a immunology stub. You can help WikiMD by expanding it!